THROMBOTIC AND THROMBOEMBOLIC COMPLICATIONS IN SYSTEMIC VASCULITIS
نویسندگان
چکیده
منابع مشابه
Venous thromboembolic events in systemic vasculitis.
In a population-base study published in the Annals of Rheumatic Disease, Aviña-Zubieta et al showed that there is almost 2.5-fold increase in risk of venous thromboembolism (VTE) in patients with giant cell arteritis (GCA) compared with that in the general population. Higher incidence of VTE is apparently not unique for GCA as a similar increase in risk of deep vein thrombosis (DVT) and pulmona...
متن کاملThromboembolic complications in myelomatosis.
claims for sick benefit reached a weekly figure of approximately 450% above the seasonal average. Strains of the Hong Kong variant of influenza virus A2 were isolated in the area. Returns from councils of absence owing to illness, believed to be influenza, during December and January were as follows. Unvaccinated 164 Off sick 41 Vaccinated once only 27 Off sick 7 Vaccinated twice 85 Off sick ni...
متن کاملThromboembolic complications in myelomatosis.
Fourteen cases of myelomatosis associated with major thromboembolic complications are reported. Six patients died of pulmonary embolism, seven had deep-vein thrombosis as a presenting symptom, and three had evidence of amyloidosis. A preliminary estimate of the incidence of thromboembolism based on 376 patients admitted so far to the Medical Research Council's myelomatosis trial is about 3%, wh...
متن کاملVenous thrombotic, thromboembolic, and mechanical complications after retrievable inferior vena cava filters for major trauma.
BACKGROUND The ideal thromboprophylaxis in patients at risk of bleeding is uncertain. This retrospective cohort study assessed the risk factors for complications after using retrievable inferior vena cava (IVC) filters for primary or secondary thromboembolism prophylaxis in patients after major trauma. METHODS Using data from radiology, trauma and death registries, the incidence of and risk f...
متن کاملThromboembolic Complications Following
Thromboembolic complications frequently occur following myocardial infarction. Following the general acceptance of anticoagulant therapy for the treatment of myocardial infarction, there have been some authors who have recommended that this therapy be withheld from "mild cases," unless they develop thromboembolic complications. It is the belief of the present authors that this is not justified ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Clinician
سال: 2017
ISSN: 2412-8775,1818-8338
DOI: 10.17650/1818-8338-2017-11-2-24-32